Vanguard Global Advisers
CDLX icon

Vanguard Global Advisers’s Cardlytics CDLX Stock Holding History

Vanguard Global Advisers’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.88K Hold
1,532
– – ﹤0.01% 3529
2026
Q1 		$16.1K Buy
+1,532
New +$14.9K ﹤0.01% 3378

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Global Advisers's CDLX Position: Q2 2026 in Review

Vanguard Global Advisers held its Cardlytics (CDLX) position steady in Q2 2026 at 1,532 shares worth $6.88K. The position accounts for ﹤0.01% of the portfolio, ranked #3529.

Vanguard Global Advisers first reported a position in CDLX in Q1 2026 and has held it in 2 quarters since. The position peaked at $16.1K in Q1 2026. 41 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Vanguard Global Advisers held 1,532 shares of Cardlytics worth $6.88K as of Q2 2026.
  • Vanguard Global Advisers left its Cardlytics share count unchanged in Q2 2026.
  • Cardlytics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3529 holding.
  • Vanguard Global Advisers first reported a position in Cardlytics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Cardlytics position peaked at $16.1K in Q1 2026.
  • 41 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.